ArticleFrontiers in pharmacology2025

Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry.

Antonio Vitale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.